Managing the Risk of Sleep Disordered Breathing during Long Term Opioid Therapy

Lynn Webster, MD

In appropriately selected patient populations, opioid medications can provide significant pain relief and improve patient function. Individualized risk: benefit analysis is critical to achieving good patient outcomes, however. Recent studies have shown that chronic opioid therapy is associated with central sleep apneas and ataxic breathing, among other neurorespiratory disturbances. Opioid receptors are located in brain regions thought to regulate sleep onset and maintenance, providing a plausible biochemical basis for the abnormal sleep architecture and sleep-disordered breathing found in many chronic pain patients receiving long-term μ-opioid therapy. While additional research is required to establish the clinical relevance of these and related findings, weighing the potential risks of chronic opioid use against known benefits requires vigilance, risk mitigation strategies, and continual patient monitoring.

References

Chronic opioid therapy and preventive services in rural primary care: an Oregon rural practice-based research network study.

Buckley DI, Calvert JF, Lapidus JA, et al.
Ann Fam Med. 2010;8(3):237-44.
PURPOSE:...

A different kind of co-morbidity: Understanding posttraumatic stress disorder and chronic pain

Beck JG, Clapp JD.
Psychol Trauma. 2011 Jun;3(2):101-108.
Many traumatic events leave...

The impact of enrollment in a specialized interdisciplinary neuropathic pain clinic

Garven A, Brady S, Wood S, Hatfield M, Bestard J, Korngut L, Toth C.
Pain Res Manag. 2011...

Association between urine drug test results and treatment outcome in high-risk chronic pain patients on opioids

Barth KS, Becker WC, Wiedemer NL, Mavandadi S, Oslin DW, Meghani SH, Gallagher RM.
J Addict...

The role of core strengthening for chronic low back pain.

Akuthota V, Standaert CJ, Chimes GP.
PM R. 2011 Jul;3(7):664-70.